SCHEMBL1015404

SCHEMBL1015404

COC(=O)c1cc(Cl)ccc1NC(=O)COCC(=O)NCc1cccc(-c2ccc(Cl)s2)c1

nearest known ligand 0.58

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SERPINE1 P05121 2/20 0.58
KDM4E B2RXH2 3/20 0.46
PLA2G1B P04054 1/20 0.41
HTT P42858 1/20 0.41
L3MBTL1 Q9Y468 1/20 0.41
ATG4B Q9Y4P1 1/20 0.41
MAPT P10636 3/20 0.41
NPSR1 Q6W5P4 2/20 0.41
ALDH1A1 P00352 2/20 0.41
MEN1 O00255 1/20 0.41
HPGD P15428 1/20 0.41
KMT2A Q03164 1/20 0.41
ANO1 Q5XXA6 1/20 0.40
CRHBP P24387 1/20 0.39
CRHR2 Q13324 1/20 0.39
POLB P06746 1/20 0.38
G6PD P11413 1/20 0.38
GAA P10253 2/20 0.38
CNR1 P21554 1/20 0.38
SMN1; SMN2 Q16637 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1015852 0.92 SERPINE1 (0.57) SERPINE1KDM4EPLA2G1BHTTL3MBTL1
SCHEMBL1016045 0.91 SERPINE1 (0.69) SERPINE1KDM4EPLA2G1BHTTL3MBTL1
SCHEMBL1015851 0.88 SERPINE1 (0.58) SERPINE1KDM4EPLA2G1BHTTL3MBTL1
SCHEMBL1015937 0.84 SERPINE1 (0.67) SERPINE1KDM4EPLA2G1BHTTL3MBTL1
SCHEMBL1015659 0.84 SERPINE1 (0.60) SERPINE1KDM4EPLA2G1BHTTL3MBTL1
SCHEMBL1015802 0.82 SERPINE1 (0.84) SERPINE1KDM4EPLA2G1BHTTL3MBTL1
SCHEMBL1015337 0.82 SERPINE1 (0.62) SERPINE1KDM4EPLA2G1BHTTL3MBTL1
SCHEMBL1017187 0.82 SERPINE1 (0.57) SERPINE1KDM4EPLA2G1BHTTL3MBTL1
SCHEMBL1015582 0.79 SERPINE1 (0.69) SERPINE1KDM4EPLA2G1BHTTL3MBTL1
SCHEMBL1013725 0.75 SERPINE1 (0.72) SERPINE1KDM4EPLA2G1BHTTL3MBTL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8415479-B2 Inhibitor of plasminogen activator inhibitor-1 RENASCIENCE CO., LTD. (JP) 2013-04-09 US disclosed
US-20110112140-A1 INHIBITOR OF PLASMINOGEN ACTIVATOR INHIBITOR-1 RENASCIENCE CO., LTD. (JP) 2011-05-12 US disclosed
EP-2272822-A1 INHIBITOR OF PLASMINOGEN ACTIVATOR INHIBITOR-1 Renascience CO., LTD. (JP) 2011-01-12 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110112140-A1 INHIBITOR OF PLASMINOGEN ACTIVATOR INHIBITOR-1 SERPINE1, SERPINB1, SERPINC1 SERPINE1 1/4885KDM4E 4108/4885PLA2G1B 263/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.